These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 11146763

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia.
    Lieberman JA, Yunis J, Egea E, Canoso RT, Kane JM, Yunis EJ.
    Arch Gen Psychiatry; 1990 Oct; 47(10):945-8. PubMed ID: 2222133
    [Abstract] [Full Text] [Related]

  • 4. The major histocompatibility complex region marked by HSP70-1 and HSP70-2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups.
    Corzo D, Yunis JJ, Salazar M, Lieberman JA, Howard A, Awdeh Z, Alper CA, Yunis EJ.
    Blood; 1995 Nov 15; 86(10):3835-40. PubMed ID: 7579351
    [Abstract] [Full Text] [Related]

  • 5. Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens.
    Dettling M, Cascorbi I, Opgen-Rhein C, Schaub R.
    Pharmacogenomics J; 2007 Oct 15; 7(5):325-32. PubMed ID: 17001352
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. HLA associations in clozapine-induced agranulocytosis.
    Yunis JJ, Corzo D, Salazar M, Lieberman JA, Howard A, Yunis EJ.
    Blood; 1995 Aug 01; 86(3):1177-83. PubMed ID: 7620171
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
    Meged S, Stein D, Sitrota P, Melamed Y, Elizur A, Shmuelian I, Gazit E.
    Int Clin Psychopharmacol; 1999 Sep 01; 14(5):305-12. PubMed ID: 10529073
    [Abstract] [Full Text] [Related]

  • 10. Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis.
    Verbelen M, Collier DA, Cohen D, MacCabe JH, Lewis CM.
    Pharmacogenomics J; 2015 Oct 01; 15(5):461-6. PubMed ID: 25732907
    [Abstract] [Full Text] [Related]

  • 11. Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis.
    Athanasiou MC, Dettling M, Cascorbi I, Mosyagin I, Salisbury BA, Pierz KA, Zou W, Whalen H, Malhotra AK, Lencz T, Gerson SL, Kane JM, Reed CR.
    J Clin Psychiatry; 2011 Apr 01; 72(4):458-63. PubMed ID: 20868635
    [Abstract] [Full Text] [Related]

  • 12. Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis.
    Tiwari AK, Need AC, Lohoff FW, Zai CC, Chowdhury NI, Müller DJ, Putkonen A, Repo-Tiihonen E, Hallikainen T, Yağcıoğlu AE, Tiihonen J, Kennedy JL, Meltzer HY.
    Mol Psychiatry; 2014 Apr 01; 19(4):403-5. PubMed ID: 23752246
    [No Abstract] [Full Text] [Related]

  • 13. Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry.
    Dettling M, Schaub RT, Mueller-Oerlinghausen B, Roots I, Cascorbi I.
    Pharmacogenetics; 2001 Mar 01; 11(2):135-41. PubMed ID: 11266078
    [Abstract] [Full Text] [Related]

  • 14. Human leukocyte antigen system in clozapine-induced agranulocytosis.
    Theodoropoulou S, Pappa H, Lykouras L, Papageorgiou G, Papasteriades C, Sakalis G.
    Neuropsychobiology; 1997 Mar 01; 36(1):5-7. PubMed ID: 9211436
    [Abstract] [Full Text] [Related]

  • 15. Association between clozapine-induced agranulocytosis and HLA subtyping.
    Lopez-Garcia P, Teresa Rodriguez J, De Castro P, Landecho I, Zapata R.
    J Clin Psychiatry; 2006 Oct 01; 67(10):1652-3. PubMed ID: 17107265
    [No Abstract] [Full Text] [Related]

  • 16. The historical and geomedical immunogenetics of pemphigus among the descendants of Sephardic Jews in New Mexico.
    Bordenave K, Griffith J, Hordes SM, Williams TM, Padilla RS.
    Arch Dermatol; 2001 Jun 01; 137(6):825-6. PubMed ID: 11405787
    [No Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine.
    Girardin FR, Poncet A, Perrier A, Vernaz N, Pletscher M, F Samer C, Lieberman JA, Villard J.
    Pharmacogenomics J; 2019 Apr 01; 19(2):211-218. PubMed ID: 29298994
    [Abstract] [Full Text] [Related]

  • 18. Mitchell B. Balter Award. Human leukocyte antigen-A1 predicts a good therapeutic response to clozapine with a low risk of agranulocytosis in patients with schizophrenia.
    Lahdelma L, Ahokas A, Andersson LC, Suvisaari J, Hovatta I, Huttunen MO, Koskimies S.
    J Clin Psychopharmacol; 2001 Feb 01; 21(1):4-7. PubMed ID: 11199946
    [Abstract] [Full Text] [Related]

  • 19. Clozapine rechallenge after excluding the high-risk clozapine-induced agranulocytosis genotype of HLA-DQB1 6672G>C.
    McKnight C, Guirgis H, Votolato N.
    Am J Psychiatry; 2011 Oct 01; 168(10):1120. PubMed ID: 21969051
    [No Abstract] [Full Text] [Related]

  • 20. How close are we to a pharmacogenomic test for clozapine-induced agranulocytosis?
    Verbelen M, Lewis CM.
    Pharmacogenomics; 2015 Oct 01; 16(9):915-7. PubMed ID: 26122865
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.